Dominic Stone
Kadcyla (ado-trastuzumab emtansine) is a targeted anti-cancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered through the vein as an infusion once every three weeks. While Kadcyla has been life-saving for many patients, it can cause a variety of side effects, ranging from mild to severe. One of the commonly reported side effects of Kadcyla is muscle pain. In addition to muscle pain, other side effects may include nausea, fatigue, headache, bone pain, joint pain, and abdominal pain. Some serious side effects have also been reported, such as liver damage, heart problems, infusion reactions, and bleeding disorders. It is important for patients to closely monitor their health and report any concerning symptoms to their healthcare provider promptly.
| Characteristics | Values |
|---|---|
| Muscle pain | Common side effect |
| Other names | Ado-trastuzumab emtansine, Trastuzumab emtansine |
| Usage | Treat HER2-positive breast cancer |
| Administration | Intravenous infusion once every 3 weeks |
| Common side effects | Nausea, fatigue, headache, bone pain, joint pain, abdominal pain, constipation, vomiting, diarrhea, dry mouth, stomatitis, dyspepsia, hair loss, blurred vision, high blood pressure, peripheral neuropathy, hemorrhage, thrombocytopenia, anemia, urinary tract infection, hepatotoxicity, hepatic failure, nodular regenerative hyperplasia, portal hypertension, lung problems, interstitial lung disease, nerve damage, serious bleeding, low platelet count, infusion-related reactions, life-threatening bleeding, liver problems, heart problems, infertility |
| Serious side effects | Infusion-related reactions, extravasation, low platelet count, lung problems, nerve damage, severe peripheral neuropathy, hemorrhage, thrombocytopenia, serious bleeding, low white blood cell count, heart failure, liver disease, blurred vision, high blood pressure |
| Precautions | Not safe during pregnancy or breastfeeding, may harm unborn baby, avoid during infectious diseases, may cause allergic reactions, may cause infertility |
Explore related products
What You'll Learn
- Kadcyla may cause muscle pain as a common side effect
- Kadcyla can cause serious bleeding, which may be life-threatening
- Kadcyla may cause nerve damage, leading to numbness and weakness
- Kadcyla may cause liver damage, with symptoms like nausea and abdominal pain
- Kadcyla may increase the risk of heart problems and heart failure
Kadcyla may cause muscle pain as a common side effect
Kadcyla (ado-trastuzumab emtansine) is a targeted anticancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered through the vein as an infusion once every three weeks.
While Kadcyla is an effective treatment, it can cause a range of side effects, some of which are mild, while others are more serious. One of the more common side effects of Kadcyla is muscle pain. Muscle pain can manifest as tightness in the chest muscles, muscle cramps, or pain in the muscles, bones, ligaments, and tendons.
In addition to muscle pain, Kadcyla may also cause nausea, fatigue, headache, joint pain, and bone pain. Some patients may also experience infusion-related reactions, such as flushing, chills, fever, trouble breathing, low blood pressure, wheezing, and a fast heartbeat.
It is important to note that Kadcyla can also cause serious and potentially fatal side effects, such as liver disease, nerve damage, heart problems, and severe bleeding. Patients experiencing any side effects during treatment should consult their doctor immediately.
Overall, while Kadcyla is a valuable treatment option for HER2-positive breast cancer, it is important for patients to be aware of the potential side effects, including muscle pain, and to seek medical advice if necessary.
Glucosamine Sulfate: Muscle Cramps and How to Avoid Them
You may want to see also
Explore related products
Kadcyla can cause serious bleeding, which may be life-threatening
Kadcyla (ado-trastuzumab emtansine) is a targeted anticancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered by a healthcare professional as an infusion through a vein once every three weeks.
While Kadcyla is an effective treatment, it can cause a range of side effects, some of which may be serious or even life-threatening. One of the most concerning side effects is the risk of serious bleeding, which may be fatal in rare cases.
Firstly, it is important to note that Kadcyla can lower your platelet count. Platelets are essential for blood clotting and help to stop bleeding. When your platelet count is low, you may experience easy bruising, bleeding gums or nose bleeds, and prolonged bleeding from cuts. This can increase the risk of serious bleeding, which may be life-threatening.
Additionally, taking Kadcyla with other medications that thin the blood or prevent blood clots can further elevate the risk of bleeding. Therefore, it is crucial to inform your doctor about any other medications you are taking to ensure proper monitoring.
In rare instances, Kadcyla may cause life-threatening bleeding even when blood thinners are not being taken concurrently. This bleeding typically occurs inside the body and may be a sign of severe internal hemorrhage. Symptoms of serious bleeding may include weakness on one side of the body, trouble speaking, vision changes, confusion, severe abdominal pain, trouble breathing, and bloody vomit or black/tarry stools.
If you experience any of these symptoms or signs of bleeding, it is imperative to seek immediate medical attention. Do not hesitate to call for emergency services or contact your healthcare provider right away.
Weak Leg Muscles: Causes and Solutions
You may want to see also
Explore related products
![On Myalgia : Its Nature, Causes, and Treatment : Being a Treatise on Painful and Other Affections of the Muscular System, Which Have Been Frequently Mistaken for Hysterical, 1860 [Leather Bound]](https://m.media-amazon.com/images/I/617DLHXyzlL._AC_UY218_.jpg)
Kadcyla may cause nerve damage, leading to numbness and weakness
Kadcyla (ado-trastuzumab emtansine) is a targeted anticancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered through the vein as an infusion once every three weeks.
While Kadcyla is an effective treatment, it can cause a range of side effects, including muscle pain. This medication commonly causes side effects like nausea, fatigue, headache, and muscle or joint pain. However, more serious side effects have also been reported, including nerve damage, which can lead to numbness and weakness.
Nerve damage, or peripheral neuropathy, is a recognised serious side effect of Kadcyla. This can cause numbness, tingling, or weakness in the hands or feet. If you experience any of these symptoms, it is important to contact your doctor immediately. Peripheral neuropathy can be a debilitating condition, impacting the patient's quality of life.
In addition to nerve damage, Kadcyla may also cause other serious side effects, including liver problems, heart failure, infusion reactions, lung problems, and low platelet counts. Liver problems can manifest as nausea, vomiting, abdominal pain, dark urine, and jaundice. Heart failure symptoms may include shortness of breath, swelling of the ankles or feet, unusual tiredness, and sudden weight gain. Infusion reactions can be life-threatening and require immediate medical attention. Lung problems, such as interstitial lung disease, can further complicate a patient's health, and low platelet counts increase the risk of severe bleeding.
It is important for patients undergoing Kadcyla treatment to be aware of these potential side effects and to seek medical advice if they experience any concerning symptoms. While Kadcyla can be an effective treatment for HER2-positive breast cancer, careful monitoring and management of side effects are crucial to ensure patient safety and well-being.
Constipation and Muscle Stiffness: Is There a Link?
You may want to see also
Kadcyla may cause liver damage, with symptoms like nausea and abdominal pain
Kadcyla (ado-trastuzumab emtansine) is a targeted anti-cancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered through the vein once every three weeks.
While Kadcyla is an effective treatment, it can cause a range of side effects, some of which may be serious. One of the more common side effects is abdominal pain, which can be a symptom of underlying liver damage. This pain was reported in the drug's clinical studies, although it was not among the more frequently reported side effects. Typically, abdominal pain related to Kadcyla is mild or moderate and not considered serious. However, it is crucial to monitor this symptom as it can indicate liver damage.
Liver problems can manifest with various symptoms, including nausea, vomiting, loss of appetite, an eating disorder (anorexia), a yellow tint in the eyes or skin (jaundice), dark urine, itching, and abdominal pain. These symptoms may indicate liver disease or liver injury, which can be life-threatening. Therefore, it is imperative to seek immediate medical attention if any of these symptoms occur.
The risk of liver damage is heightened when Kadcyla is taken in conjunction with certain other medications. For example, taking the antibiotic clarithromycin with Kadcyla can increase the likelihood of liver injury and other side effects. Additionally, Kadcyla may cause serious heart problems, including heart failure, especially if the patient has a history of certain heart conditions or has previously taken specific anti-cancer drugs like anthracyclines. It is important to consult a doctor immediately if any symptoms of heart failure develop, such as shortness of breath, swelling of ankles or feet, unusual tiredness, or sudden weight gain.
In summary, while Kadcyla is a valuable treatment option for HER2-positive breast cancer, it is important to be vigilant for any signs of liver damage, including abdominal pain and other symptoms of liver problems. The potential for drug interactions and heart complications further underscores the necessity of careful medical supervision and prompt reporting of any adverse effects.
Muscle Contusion and Fever: Is There a Link?
You may want to see also
Kadcyla may increase the risk of heart problems and heart failure
Kadcyla (ado-trastuzumab emtansine) is a targeted anti-cancer medication used to treat HER2-positive breast cancer in patients who have previously received cancer therapy. It is administered as an infusion through a vein once every three weeks.
While Kadcyla is an effective treatment, it is associated with several side effects, and it may increase the risk of heart problems and heart failure.
Firstly, Kadcyla can cause a range of mild to moderate side effects, including muscle pain, nausea, fatigue, and headache. More rarely, it can lead to serious and potentially fatal health issues, including liver disease and heart failure.
In terms of heart problems, Kadcyla may increase the risk of heart failure, particularly in those with a history of certain heart conditions. Before and during treatment, doctors closely monitor patients' heart health by measuring their left ventricular ejection fraction (LVEF), which indicates the amount of blood the heart can pump. If a patient's LVEF becomes too low, doctors will pause treatment and recommend alternatives if necessary. Therefore, it is crucial to inform your doctor if you experience any symptoms of heart problems, such as shortness of breath, swelling of the ankles or feet, unusual tiredness, or sudden weight gain, as these could be indicative of heart failure.
Additionally, Kadcyla has been associated with an increased risk of bleeding, which can be life-threatening. This risk is heightened when taking Kadcyla concurrently with blood-thinning medications or other drugs. Patients should be vigilant for signs of bleeding, such as easy bruising, bleeding from cuts, or unusual bleeding from the nose or gums, and seek medical attention if these occur.
Furthermore, Kadcyla can cause liver problems, and in rare cases, it has been linked to very serious, possibly fatal, liver disease. Symptoms of liver problems include nausea, abdominal pain, dark urine, and yellowing of the eyes or skin (jaundice). Patients experiencing these symptoms should seek immediate medical assistance.
It is important to note that the side effects of Kadcyla vary among individuals, and not all patients will experience the same issues. Patients should always consult their healthcare providers to understand how this medication may affect them specifically and to ensure safe and effective treatment.
Muscle Spasms: A Cause of Leg Numbness?
You may want to see also
Frequently asked questions
Yes, muscle pain is a common side effect of Kadcyla. It can also cause bone, joint, and ligament pain.
Muscle pain is a common side effect of Kadcyla and usually nothing to worry about. However, if you experience severe or persistent muscle pain, you should contact your doctor.
Yes, Kadcyla has been known to cause a wide range of mild to severe side effects, including nausea, fatigue, headache, abdominal pain, hair loss, and bleeding. It can also cause serious health problems, including liver disease, heart failure, and lung problems. If you experience any unusual or severe symptoms, you should contact your doctor immediately.
